Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06144996

Development of a Canadian Bronchiectasis and NTM Database

The investigators aim to develop a comprehensive patient registry of patients with non-CF bronchiectasis and/or Nontuberculosis Mycobacteria (NTM)

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–120 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

The investigators aim to develop a comprehensive patient registry of patients with non-CF bronchiectasis and/or Nontuberculosis Mycobacteria (NTM). This will entail inclusion of adults (age >18 years) with a diagnosis of these conditions to be entered with complete clinical data and quality of life assessments entered into a patient registry.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Over the age of 18
  • Non-CF Bronchiectasis
  • Nontuberculosis Mycobacteria (NTM)

Exclusion criteria

  • Under the age of 18
  • CF bronchiectasis

Treatment and study plan

Primary outcomes

  1. Patient Recruitment and Data analysis for NTM and Bronchiectasis

    Time frame: December 2050

    Descriptive analysis of demographics and clinical parameters and epidemiological evaluation of No. of hospitalizations, No. of exacerbations.

Sponsors and collaborators

Lead sponsor

University of Calgary

Other

Collaborators

  • Insmed Incorporated
  • Trudell Medical International

Registry information

Important dates

Study start
2023
Primary completion
2050
Study completion
2050
First posted
Nov 22, 2023
Registry last updated
Nov 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.